The International Finance Facility for Immunisation (IFFIm) was founded in 2006 and is headquartered in London, UK, with a mission to accelerate the availability of funds for immunisation programs worldwide. IFFIm issues bonds to raise funds that help support global vaccination initiatives, particularly in low-income countries, thereby contributing significantly to public health improvements.
| Bond Name | Country | Maturity | Coupon(%) | |
|---|---|---|---|---|
| IFFIM 0.00% 2030-04-05 NOKInternational Finance Facility for Immunisation | United Kingdom | 2030-04-05 | 0.000 | 4.24 |
| IFFIM 0.50% 2027-06-29 ZARInternational Finance Facility for Immunisation | United Kingdom | 2027-06-29 | 0.500 | 8.08 |
| IFFIM 1.00% 2026-04-21 USDInternational Finance Facility for Immunisation | United Kingdom | 2026-04-21 | 1.000 | 4.02 |
| IFFIM 2.75% 2025-06-07 GBPInternational Finance Facility for Immunisation | United Kingdom | 2025-06-07 | 2.750 | 0.00 |
| IFFIM 4.75% 2025-11-03 USDInternational Finance Facility for Immunisation | United Kingdom | 2025-11-03 | 4.750 | 4.46 |
Company overview and issue history are AI generated, and should not be cited or relied on without verification.
Since its inception, IFFIm has issued over $5 billion in bonds, with significant issuances aimed at advancing global vaccine access. Notably, the debut bond issuance occurred in 2006, which raised $1 billion and marked a pivotal moment for public health financing. Current yields on IFFIm bonds remain competitive within the social impact bond market, and the organization has embraced innovative bond features, such as its Vaccine Bonds, to attract retail investors while continuing to address critical health challenges globally.